You are here

ASCO 2018 Roundtable - Checkmate 227 - Combinations of Nivolumab and Ipilimumab, or Nivolumab and and Chemo

ASCO 2018 Roundtable

H. Jack West, MD, Founder, President and CEO

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.

In this roundtable video, the doctors discuss Checkmate 227 - Combinations of Nivolumab and Ipilimumab, or Nivolumab and Chemotherapy.

GRACE thanks the following sponsors for their support.

Video Language:

English

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

form.antibot { display: none !important; } You must have JavaScript enabled to use this form.

Related Content

Supportive Care - Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Video

We are very excited to bring to you this new program on supportive care in cancer treatment. Arjun Gupta, MD, one of the GRACE Fellows Ambassador Program Winners for 2019 is the host of this video series, Supportive Care in Cancer Treatment. In this first video, Dr. Gupta's guest is Charles Loprinzi, MD, with the Mayo Clinic in Rochester, MN. Their topic of discussion is Chemotherapy-induced peripheral neuropathy (CIPN).

STK11, KEAP as Targets, What Are They, and Should Results Enter Into Clinical Decision Making

Video

We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services at City of Hope Comprehensive Cancer Center, and Founder, President and CEO Of GRACE, Charu Aggarwal, MD, MPH with the Perelman Center for Advanced Medicine, University of Pennsylvania, and Benjamin Levy MD, Clinical Director Of Medical Oncology, Assistant Professor Of Oncology at the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital.